A resin-forming promoter for agarwood containing Ganoderma lucidum extract and its preparation process
By using a covalent ester graft of Ganoderma lucidum polysaccharide and 12-oxophytic dienoic acid, the problems of short retention time of free signal molecules and difficulty in characterizing Ganoderma lucidum water extract components in the existing technology have been solved, thereby improving the agarwood formation effect and efficiently preserving characteristic components.
Patent Information
- Application Number
- CN202611364395.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-04
- Publication Date
- 2026-11-17
AI Technical Summary
In existing artificial resin formation methods, the retention time of free signal molecules at the wound site is limited, and the crude extract components of Ganoderma lucidum water extract that have not been separated by alcohol precipitation are difficult to characterize, resulting in poor resin formation effect.
A covalent ester graft compound consisting of Ganoderma lucidum polysaccharide and 12-oxophytic terpene acid (OPDA) linked by ester bonds was used to form an agarwood induction promoter. The specific monosaccharide ratio and molecular weight distribution of Ganoderma lucidum polysaccharide enhanced its affinity with plant cell walls, and the release of OPDA was controlled by the stability of the ester bonds.
This study achieved effective retention and sustained release of the covalent ester graft of Ganoderma lucidum polysaccharide and OPDA at the wound site, enhancing the resin formation effect of agarwood and improving the retention and release kinetic matching of characteristic components.
Smart Images

Figure CN123100626A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of artificial agarwood formation technology, specifically relating to an agarwood formation promoter containing Ganoderma lucidum extract and its preparation process. Background Technology
[0002] Aquilaria sinensis can form resinous heartwood in its xylem under conditions such as trauma and biological stress. Current artificial aquilaria formation typically involves drilling to create wounds and then applying chemical signaling molecules, microbial agents, or combinations thereof. Free small molecules tend to migrate or be lost at the wound site, resulting in limited local retention time after a single application.
[0003] Therefore, there is a need for an agarwood induction promoter that uses a skeleton that can characterize the polysaccharide fraction of Ganoderma lucidum and carries plant signaling molecules in a covalently bound form, in order to control the quality of raw materials and the content of free signaling molecules.
[0004] The "meat lingzhi" mentioned in this invention refers to a slime mold-bacteria-fungus complex that grows in North and Northwest my country, commonly known as "Tai Sui" or "meat lingzhi". Summary of the Invention
[0005] To address the aforementioned issues, this invention provides an agarwood resin-forming promoter containing Ganoderma lucidum extract and its preparation process. This effectively solves the problems of limited retention of existing free signaling molecule-based resin-forming inducers at wound sites and the difficulty in characterizing the components of crude extracts obtained from Ganoderma lucidum water extracts without alcohol precipitation.
[0006] This invention proposes an agarwood resin-forming promoter, comprising a covalent ester graft of Ganoderma lucidum polysaccharide and 12-oxophytic dienoic acid (OPDA), wherein the glycosyl hydroxyl group of Ganoderma lucidum polysaccharide and the carboxyl group of OPDA are linked by an ester bond.
[0007] Furthermore, the aforementioned Ganoderma lucidum polysaccharide refers to the polysaccharide fraction obtained from the aqueous extract of Ganoderma lucidum raw material through protein removal and alcohol precipitation separation.
[0008] Furthermore, the Ganoderma lucidum polysaccharide was obtained from the aqueous extract of Ganoderma lucidum through protein removal and alcohol precipitation, with a weight-average molecular weight of 5 × 10⁻⁶. 4 -3×10 5 Da, the main monosaccharides include glucose, galactose, mannose, rhamnose and glucuronic acid, with a molar ratio of (3.3-3.7):(1.9-2.1):(1.4-1.6):(0.9-1.1):(0.7-0.9), and the residual protein content is not higher than 2.0%.
[0009] Furthermore, when preparing the covalent ester graft, the mass ratio of Ganoderma lucidum polysaccharide to 12-oxophytic dienoic acid is (1-5):1.
[0010] Furthermore, the mass of free 12-oxophytic dienoic acid (12-oxophytic acid) before hydrolysis and the total mass of 12-oxophytic acid after hydrolysis in 0.2 mol / L sodium hydroxide solution at 37°C for 30 min were determined. The percentage of the difference between the total mass after hydrolysis and the free mass before hydrolysis, as a percentage of the dry mass of the graft, was used to determine the 12-oxophytic acid content, which ranged from 5.8% to 27.3%. Based on the dry mass of the graft, the free 12-oxophytic acid content was determined by high-performance liquid chromatography (HPLC) to be no higher than 1.0%.
[0011] This invention also proposes a preparation process for an agarwood resin-forming promoter containing Ganoderma lucidum extract, specifically including the following steps:
[0012] (1) Extract the raw material of Ganoderma lucidum with water at 70-90℃ for 2-6 h, remove the protein from the water extract and separate it by alcohol precipitation with 70%-80% ethanol to obtain Ganoderma lucidum polysaccharide fraction;
[0013] (2) The carboxyl group of 12-oxophyte dienoic acid is activated by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to form N-hydroxysuccinimide active ester.
[0014] (3) The activated solution obtained in step (2) is added to a dimethyl sulfoxide / water mixed solution containing Ganoderma lucidum polysaccharide fraction and 4-dimethylaminopyridine within 30 min after preparation, so that the N-hydroxysuccinimide active ester and the glycosyl hydroxyl group of Ganoderma lucidum polysaccharide undergo esterification grafting reaction to obtain crude grafted product.
[0015] (4) Purify the crude graft product to remove free 12-oxophytic dienoic acid and obtain agarwood inoculation promoter.
[0016] Furthermore, in step (1), the water extraction temperature is 70-90℃, the water extraction time is 2-6 h each time, and the final concentration of ethanol after alcohol precipitation is 70%-80%.
[0017] Further, in step (2), the molar ratio of 12-oxophytic dienoic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide is 1:1.2:1.5; first, 12-oxophytic dienoic acid and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride are mixed and reacted for 15 min, and then N-hydroxysuccinimide is added and the reaction is continued for 15 min.
[0018] Further, in step (3), the volume ratio of dimethyl sulfoxide to water is 1:(0.5-2), the amount of 4-dimethylaminopyridine is 5%-15% of the molar amount of 12-oxophytic dienoic acid, the reaction temperature is 20-40℃, and the reaction time is 12-36 h.
[0019] Preferably, in step (3), the volume ratio of dimethyl sulfoxide to water is 1:1. The activation solution obtained in step (2) is added dropwise to a dimethyl sulfoxide / water mixed solution containing Ganoderma lucidum polysaccharide fraction and 4-dimethylaminopyridine. After the addition is completed, the solution is reacted at 25°C in the dark for 24 h.
[0020] Furthermore, in step (4), the crude grafted product is purified by at least one of dialysis, ultrafiltration or column separation.
[0021] Furthermore, the accelerator can be formulated as a water-dispersible agent, paste, or gel. The water-dispersible agent is prepared by dispersing the graft at a concentration of 5%-15% (w / v) in a phosphate buffer solution at pH 7.0 and stirring until homogeneous. The paste is prepared by mixing the graft with petrolatum at a mass ratio of 1:(2-5) and grinding until homogeneous. The gel is prepared by mixing the graft with an aqueous solution of sodium carboxymethyl cellulose at a concentration of 10%-20% (w / v) and stirring until homogeneous. For a single application to the wound site of *Aquilaria sinensis* trees, the dosage per tree is 0.05-0.3 g, calculated as 12-oxophytic dienoic acid.
[0022] The beneficial effects achieved by adopting the above technical solution are as follows: The polysaccharide fractions of Ganoderma lucidum have molecular weight, main monosaccharide, and protein residue indicators, facilitating raw material quality control; the difference in OPDA content before and after alkaline hydrolysis can be used to quantify the apparent bound OPDA content in the graft; infrared spectroscopy, nuclear magnetic resonance, and SEC-UV detection can serve as auxiliary characterization methods for esterified graft structures; Ganoderma lucidum polysaccharides contain a specific ratio of glucuronic acid (approximately 0.7-0.9 molar ratio) and rhamnose (approximately 0.9-1.1 molar ratio), and these charged or branched monosaccharide units can enhance the affinity between the polysaccharide skeleton and the plant cell wall, promoting the retention of the graft at the wound site; simultaneously, the weight-average molecular weight distribution of Ganoderma lucidum polysaccharides (5×10⁻⁶) is... 4 -3×10 5 OPDA (dimethylglucan) provides the grafted material with moderate steric hindrance, protecting it from rapid loss in the early stages of application while allowing for the gradual release of active molecules by esterases in the tree, with release kinetics matching the wound defense signal window. In contrast, the dextran backbone lacks charged groups and branched structures, exhibits weak affinity for plant cell walls, and has a uniform molecular weight distribution, making it difficult to achieve a similar sustained-release-recognition synergistic effect. Attached Figure Description
[0023] Figure 1 A quantitative comparison chart of characteristic components of agarwood.
[0024] Figure 2 A comparison chart of alcohol-soluble extracts from each treatment group.
[0025] Figure 3 This is a comparison of the relative peak areas of sesquiterpenes in each treatment group.
[0026] Figure 4 This is a comparison of the relative peak areas of chromones in each treatment group.
[0027] The accompanying drawings are provided to further illustrate the invention and form part of the specification. They are used together with the embodiments of the invention to explain the invention and do not constitute a limitation thereof. Detailed Implementation
[0028] The technical solutions of the present invention will be clearly and completely described below with reference to the accompanying drawings of the embodiments of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are within the scope of protection of the present invention.
[0029] Example 1
[0030] Take 500 g of Ganoderma lucidum raw material, chop it into 1-2 cm pieces, add 3 L of deionized water, and extract at 80℃ for 4 h. Centrifuge (8000 r / min, 15 min) and collect the supernatant. Add 2 L of deionized water to the residue and extract for another 4 h, then combine the supernatants. Concentrate the supernatant under reduced pressure to 1 / 5 of its original volume, add Sevag reagent (water phase to Sevag reagent volume ratio 4:1), shake for 20 min, allow to stand for separation, and collect the aqueous phase. Repeat the protein removal process 4 times. Add anhydrous ethanol to the aqueous phase to a final concentration of 75% (v / v), let stand at 4℃ for 12 h, centrifuge to collect the precipitate, wash twice each with anhydrous ethanol and acetone, and freeze-dry to obtain the Ganoderma lucidum polysaccharide fraction.
[0031] 2.00 g of Ganoderma lucidum polysaccharide fraction was dissolved in 40 mL of DMSO / water (1:1, v / v), and 0.017 g (0.14 mmol) of 4-dimethylaminopyridine was added. Separately, 0.40 g (1.37 mmol) of 12-oxophytic dienoic acid was dissolved in 10 mL of DMSO, and 0.32 g (1.67 mmol) of EDC·HCl was added. After stirring at room temperature for 15 min, 0.24 g (2.09 mmol) of NHS was added, and stirring continued for another 15 min. The activated solution was added dropwise to the polysaccharide solution within 30 min of preparation, and the reaction was carried out at 25°C in the dark for 24 h. During this process, the NHS active ester formed by the carboxyl group of OPDA underwent acyl transfer with the glycosyl hydroxyl group of Ganoderma lucidum polysaccharide under the catalysis of 4-dimethylaminopyridine, resulting in the esterification grafting reaction of Ganoderma lucidum polysaccharide and OPDA, yielding the Ganoderma lucidum polysaccharide-OPDA esterified graft. The reaction solution was placed in a dialysis bag with a molecular weight cutoff of 3500 Da and dialyzed with deionized water for 48 h, with the water changed every 8 h. The retentate was collected and freeze-dried to obtain 2.12 g of Ganoderma lucidum polysaccharide-12-oxophyte dienoic acid covalent ester graft.
[0032] Take 100 mg of graft material, add 5 mL of 0.2 mol / L sodium hydroxide solution, hydrolyze at 37℃ for 30 min, cool, adjust pH to 3.0 with formic acid, extract three times with ethyl acetate (5 mL each time), combine the organic phases and remove the solvent, then dilute to 5 mL with methanol, and determine the total mass of 12-oxophytic dienoic acid after hydrolysis. Separately, take 100 mg of graft material, add 10 mL of methanol, sonicate for 20 min, centrifuge, and determine the mass of free 12-oxophytic dienoic acid before hydrolysis. The 12-oxophytic dienoic acid content is calculated as the percentage of the difference between the total mass after hydrolysis and the free mass before hydrolysis to the dry mass of the graft material. HPLC was performed using a C18 reversed-phase column (250 mm × 4.6 mm, 5 μm). Mobile phase A was 0.1% formic acid aqueous solution, and mobile phase B was acetonitrile. The mobile phase consisted of 35% B for 0-2 min, linearly increasing to 85% B from 2-15 min, maintaining 85% B for 15-18 min, and returning to 35% B equilibrium from 18.1-23 min. The detection wavelength was 220 nm, the flow rate was 1.0 mL / min, the column temperature was 30℃, and the injection volume was 20 μL. Quantification was performed using the external standard method. Based on the difference in alkaline hydrolysis values, the apparent bound 12-oxophytic dienoic acid content of the grafted material was 5.8%, and the free 12-oxophytic dienoic acid content was 0.35%.
[0033] Example 2
[0034] 500 g of the same batch of Ganoderma lucidum raw material was taken and subjected to water extraction, protein removal, alcohol precipitation, washing, and freeze-drying as described in Example 1 to obtain Ganoderma lucidum polysaccharide fraction. 2.00 g of this polysaccharide fraction was dissolved in 40 mL of DMSO / water (1:1, v / v), and 0.042 g (0.34 mmol) of 4-dimethylaminopyridine was added. Separately, 1.00 g (3.42 mmol) of 12-oxophytic dienoic acid was dissolved in 10 mL of DMSO, and 0.79 g (4.12 mmol) of EDC·HCl was added. After stirring at room temperature for 15 min, 0.59 g (5.13 mmol) of NHS was added, and stirring continued for another 15 min. The polysaccharide solution was added dropwise within 30 min of the activated solution, and the reaction was carried out at 25°C in the dark for 24 h. The reaction solution was treated according to the dialysis, water replacement, and freeze-drying steps described in Example 1 to obtain 2.38 g of graft material.
[0035] Take 100 mg of the graft material, add 5 mL of 0.2 mol / L sodium hydroxide solution, and hydrolyze at 37℃ for 30 min. Under the HPLC conditions of Example 1, the content of bound 12-oxophytic dienoic acid was 16.2%, and the content of free 12-oxophytic dienoic acid was 0.42%.
[0036] Example 3
[0037] 500 g of the same batch of Ganoderma lucidum raw material was taken and subjected to water extraction, protein removal, alcohol precipitation, washing, and freeze-drying as described in Example 1 to obtain Ganoderma lucidum polysaccharide fraction. 2.00 g of this polysaccharide fraction was dissolved in 40 mL of DMSO / water (1:1, v / v), and 0.084 g (0.69 mmol) of 4-dimethylaminopyridine was added. Separately, 2.00 g (6.84 mmol) of 12-oxophytic dienoic acid was dissolved in 10 mL of DMSO, and 1.57 g (8.19 mmol) of EDC·HCl was added. After stirring at room temperature for 15 min, 1.18 g (10.25 mmol) of NHS was added, and stirring continued for another 15 min. The polysaccharide solution was added dropwise within 30 min of the activated solution, and the reaction was carried out at 25°C in the dark for 24 h. The reaction solution was treated according to the dialysis, water exchange, and freeze-drying steps described in Example 1 to obtain 2.75 g of graft material.
[0038] Take 100 mg of the graft material, add 5 mL of 0.2 mol / L sodium hydroxide solution, and hydrolyze at 37℃ for 30 min. Under the HPLC conditions of Example 1, the content of bound 12-oxophytic dienoic acid is 27.3%, and the content of free 12-oxophytic dienoic acid is 0.58%.
[0039] Experimental Example 1
[0040] Comparison of the effects of promoting resin formation: The grafts from Examples 1-3 were prepared into water-dispersible formulations, each containing 10 g of graft. A pH 7.0 phosphate buffer was used as the dispersion medium, and the mixture was stirred thoroughly. 10.0 mL was applied per plant, corresponding to 0.058 g, 0.162 g, and 0.273 g of bound 12-oxophytic dienoic acid in Examples 1-3, respectively. Separate groups were established: a free 12-oxophytic dienoic acid group, a physical mixture group of Ganoderma lucidum polysaccharide and 12-oxophytic dienoic acid, a dextran-12-oxophytic dienoic acid graft group, a Ganoderma lucidum polysaccharide alone group, and a blank wound group. Each plant in the free 12-oxophytic acid group contained 0.162 g of 12-oxophytic acid; each plant in the physically mixed group contained 0.838 g of Ganoderma lucidum polysaccharide and 0.162 g of 12-oxophytic acid; the dextran graft group used a weight-average molecular weight of 8.5 × 10⁻⁶ g. 4 Da, a dextran graft containing 16.2% bound 12-oxophytic acid and 0.42% free 12-oxophytic acid was applied at 1.00 g per plant; the Ganoderma lucidum polysaccharide group was applied at 0.838 g per plant. All non-blank treatments were diluted to 10.0 mL with the same dispersion medium.
[0041] Aquilaria sinensis trees aged 8-10 years, with a diameter at breast height (DBH) of 15-20 cm and uniform growth were selected. A hole was drilled 5 cm deep at a distance of 50 cm from the ground on each tree using an 8 mm diameter drill bit, with 4 holes per tree and 5 trees per group. Each treatment solution was applied once, 2.5 mL per hole; the blank wound group only required drilling. Twelve months after application, xylem blocks were sawn from the drilled holes, naturally air-dried for 7 days, and then pulverized and passed through a 60-mesh sieve. The alcohol-soluble extract was determined according to the regulations for Aquilaria sinensis in the Pharmacopoeia of the People's Republic of China (2020 edition, Part I).
[0042] Sesquiterpenes were detected by GC-MS: the chromatographic column was a DB-5MS capillary column (30 m × 0.25 mm, 0.25 μm), the carrier gas was helium, the flow rate was 1.0 mL / min; the injection port temperature was 250℃; the initial column temperature was 60℃ and held for 2 min, then increased to 280℃ at 10℃ / min and held for 5 min; an EI ion source was used, the electron energy was 70 eV, and the scan range was m / z 40-550. Chromones were detected by LC-MS: a C18 column (2.1 mm × 100 mm, 1.7 μm) was used at 35℃; mobile phase A was 0.1% formic acid aqueous solution, and mobile phase B was acetonitrile; the flow rate was 0-2 min, 20%B-50%B; 2-10 min, 50%B-90%B; 10-12 min, maintaining 90%B; and 12.1-15 min, returning to 20%B equilibrium; the flow rate was 0.3 mL / min; electrospray ionization was used in positive and negative ion modes, with a scan range of m / z 100-1000. All samples were sampled at the same dry weight, using the same extraction volume and injection amount. The relative response values of sesquiterpenes and chromones were expressed as the total peak area of the target components. Data are expressed as mean ± standard deviation, n=5; one-way ANOVA and Tukey post-hoc tests were used for intergroup analysis. For ease of presentation in Table 1, the graft groups of Example 1, Example 2, Example 3, free 12-oxophytic dienoic acid, physical mixture, dextran-12-oxophytic dienoic acid graft group, Ganoderma lucidum polysaccharide alone, and blank wound group are respectively designated as Group 1, Group 2, Group 3, Group 4, Group 5, Group 6, Group 7, and Group 8. The results are shown in Table 1.
[0043] Table 1 Comparison of resin formation promotion effects among different treatment groups
[0044] Group Alcohol-soluble extract (%) relative peak area of sesquiterpenes relative peak area of chromone Group 1 18.5±1.8 62.3±5.2 45.8±3.9 Group 2 26.8±2.1 85.7±6.3 68.2±5.1 Group 3 24.2±2.0 78.5±5.8 61.4±4.7 Group 4 14.3±1.6 48.2±4.1 32.6±3.2 Group 5 12.8±1.4 42.5±3.8 28.3±2.9 Group 6 20.5±1.9 65.3±5.1 47.8±4.2 Group 7 5.2±0.7 15.8±2.0 8.3±1.4 Group 8 3.4±0.6 9.2±1.5 4.1±0.9
[0045] Under the experimental conditions, the relative peak areas of alcohol-soluble extracts, sesquiterpenes, and chromones in the grafted group of Example 2 were all higher than those in the other groups; the differences were statistically significant (P<0.05) compared with the free 12-oxophytic acid group, the physical mixture group, the Ganoderma lucidum polysaccharide alone group, and the blank wound group. The results of Examples 1-3 covered low, preferred, and high bound 12-oxophytic acid contents, with Example 2 showing the highest values in all indicators. The values of the dextran-12-oxophytic acid grafted group were lower than those of the grafted group of Example 2, indicating that under the same bound 12-oxophytic acid content, the Ganoderma lucidum polysaccharide skeleton has a better aroma-promoting effect than the dextran skeleton.
[0046] Experimental Example 2
[0047] Quantitative analysis of characteristic components of agarwood: Xylem powders from the graft group and the free 12-oxophytic dienoic acid group of Example 2 were collected after 12 months. Three sesquiterpenes—agaricone, agaricaldehyde, and isoagaricone—were quantified using GC-MS selected ion monitoring mode. Two chromones—2-(2-phenylethyl)chromone and 6-methoxy-2-(2-phenylethyl)chromone—were quantified using LC-MS multiple reaction monitoring mode. Quantification was performed using the external standard method (on a dry weight basis). The results are shown in Table 2.
[0048] Table 2 Quantitative Results of Characteristic Components of Agarwood
[0049] Characteristic components Example 2 Graft group (μg / g dry weight) Free OPDA group (μg / g dry weight) Agaric Spirool 285±32 142±21 White aldehyde 196±24 85±15 Isoflavone 153±19 68±12 2-(2-Phenylacetyl)chromone 412±45 198±28 6-Methoxy-2-(2-Phenylacetyl)chromone 327±38 145±22
[0050] Under the experimental conditions, the content of the five agarwood characteristic components in the graft group of Example 2 was 1.9-2.3 times that of the free OPDA group.
[0051] Experimental Example 3
[0052] The correlation between OPDA content and aroma-forming effect: Following the process in Example 1, the same batch of Ganoderma lucidum polysaccharide fractions were obtained. Esterification grafting reactions were then performed with OPDA to polysaccharide mass ratios of 0.1:1, 0.2:1, 0.5:1, 1:1, and 2:1, respectively, yielding five grafts with OPDA contents of 2.8%, 5.8%, 16.2%, 27.3%, and 34.5%. These five grafts were then formulated into water-soluble dispersions, with 10 g of graft per 100 mL of dispersion, using pH 7.0 phosphate buffer as the dispersion medium. Four wound holes were set up per tree in each treatment group, and 2.5 mL of the corresponding aqueous dispersion was applied to each hole, for a total application amount of 10.0 mL / tree. Therefore, the application amount of graft material in each group was 1.00 g / tree. Based on the apparent bound OPDA content in the graft material of each group, the corresponding OPDA application amounts were 0.028 g, 0.058 g, 0.162 g, 0.273 g, and 0.345 g / tree, respectively. Using the same tree age, wounding method, application method, and sampling conditions as in Experiment 1, alcohol-soluble extractives were measured after 12 months. Results: The extractives of the three graft material groups with bound OPDA content in the range of 5.8%-27.3% (5.8%, 16.2%, and 27.3%) were all ≥18.5%; the extractives of the 2.8% group were only 10.1%, and the extractives of the 34.5% group were 19.3%. The highest extract content (26.8%) was observed when the bound OPDA content was 16.2%. The extract content in the 34.5% group was lower than that in the 16.2% and 27.3% groups, suggesting that excessively high bound OPDA content may reduce esterase accessibility due to steric hindrance, thus hindering OPDA release. Based on these results, the recommended bound 12-oxophytic acid content is 5.8%–27.3%, with actual implementation covering this range, and 16.2% being the preferred value.
[0053] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.
[0054] The present invention and its embodiments have been described above. This description is not restrictive, and the accompanying drawings are only one embodiment of the present invention. In conclusion, if those skilled in the art are inspired by this description and design similar structures and embodiments without departing from the spirit of the present invention, such designs should fall within the protection scope of the present invention.
Claims
1. A resin-forming promoter for agarwood containing Ganoderma lucidum extract, characterized in that, It includes OPDA-esterified Ganoderma lucidum polysaccharide; the OPDA-esterified Ganoderma lucidum polysaccharide is a covalent ester graft formed by Ganoderma lucidum polysaccharide and 12-oxophytic dienoic acid, wherein the glycosyl hydroxyl group of the Ganoderma lucidum polysaccharide and the carboxyl group of the 12-oxophytic dienoic acid are connected by ester bonds.
2. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 1, characterized in that: The polysaccharide of Ganoderma lucidum is a polysaccharide fraction obtained by removing protein and separating by alcohol precipitation from the aqueous extract of Ganoderma lucidum raw material.
3. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 1, characterized in that: The weight-average molecular weight of Ganoderma lucidum polysaccharide is 5 × 10⁻⁶. 4 -3×10 5 Da.
4. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 1, characterized in that: The main monosaccharides in Ganoderma lucidum polysaccharides include glucose, galactose, mannose, rhamnose, and glucuronic acid.
5. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 4, characterized in that: The molar ratio of glucose, galactose, mannose, rhamnose and glucuronic acid is (3.3-3.7):(1.9-2.1):(1.4-1.6):(0.9-1.1):(0.7-0.9).
6. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 2, characterized in that: The polysaccharide of Ganoderma lucidum was obtained by extracting Ganoderma lucidum raw material with water at 70-90℃ for 2-6 h, followed by protein removal treatment and separation by alcohol precipitation with ethanol at a final concentration of 70%-80%.
7. The agarwood resin-forming promoter containing Ganoderma lucidum extract according to claim 1, characterized in that: When preparing OPDA-esterified Ganoderma lucidum polysaccharide, the mass ratio of Ganoderma lucidum polysaccharide to 12-oxophytic dienoic acid is (1-5):
1.
8. A method for preparing the agarwood resin-forming promoter containing Ganoderma lucidum extract as described in claim 1, characterized in that: Includes the following steps: (1) Extract the raw material of Ganoderma lucidum with water at 70-90℃ for 2-6 h, remove the protein from the water extract, and then separate it by alcohol precipitation with 70%-80% ethanol to obtain Ganoderma lucidum polysaccharide fraction. (2) The carboxyl group of 12-oxophyte dienoic acid is activated by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to form N-hydroxysuccinimide active ester. (3) The activated solution obtained in step (2) is added to a dimethyl sulfoxide / water mixed solution containing Ganoderma lucidum polysaccharide fraction and 4-dimethylaminopyridine within 30 min after preparation, so that the N-hydroxysuccinimide active ester and the glycosyl hydroxyl group of Ganoderma lucidum polysaccharide undergo esterification grafting reaction to obtain crude grafted product. (4) Purify the crude graft product to remove free 12-oxophytic dienoic acid and obtain agarwood inoculation promoter.
9. The method according to claim 8, characterized in that: In step (2), the molar ratio of 12-oxophytic dienoic acid, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide is 1:1.2:1.
5. First, 12-oxophytic dienoic acid and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride are mixed and reacted for 15 min. Then, N-hydroxysuccinimide is added and the reaction continues for 15 min. In step (3), the volume ratio of dimethyl sulfoxide to water is 1:
1. The activated solution obtained in step (2) is added dropwise to a dimethyl sulfoxide / water mixed solution containing Ganoderma lucidum polysaccharide fraction and 4-dimethylaminopyridine. After the addition is completed, the solution is reacted at 25°C in the dark for 24 h.
10. The method according to claim 8, characterized in that: In step (3), the volume ratio of dimethyl sulfoxide to water is 1:(0.5-2), the amount of 4-dimethylaminopyridine is 5%-15% of the molar amount of 12-oxophytic dienoic acid, the reaction temperature is 20-40℃, the reaction time is 12-36 h, and the purification method in step (4) is at least one of dialysis, ultrafiltration or column separation.
